TGFβ is known to stimulate FAK activation in other systems, such as myofibroblast differentiation from fibroblasts [43,62,63] and in cancer cells [64-66], thus this change in FAK activation may occur as a direct consequence of loss of TGFβ family signaling in the lenses of these transgenic mice. The gene discussed is PTK2; the disease is cancer.